Boothbay Fund Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Boothbay Fund Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,552	Closed	-$433K	–	2269
2026 Q1	$433K	Buy	+1,552	New	+$447K	0.01%	1422
2025 Q4	–	Sell	-716	Closed	-$201K	–	1983
2025 Q3	$201K	Sell	716 -6,180	-90%	-$1.68M	﹤0.01%	1644
2025 Q2	$1.66M	Buy	+6,896	New	+$1.63M	0.03%	545
2024 Q4	–	Sell	-872	Closed	-$292K	–	1514
2024 Q3	$292K	Sell	872 -69	-7%	-$21.9K	0.01%	1264
2024 Q2	$257K	Buy	+941	New	+$274K	0.01%	1210
2023 Q2	–	Sell	-588	Closed	-$282K	–	1831
2023 Q1	$282K	Buy	+588	New	+$275K	0.01%	1546
2022 Q4	–	Sell	-780	Closed	-$325K	–	2012
2022 Q3	$325K	Buy	+780	New	+$389K	0.01%	1475
2022 Q2	–	Sell	-466	Closed	-$262K	–	2262
2022 Q1	$262K	Buy	+466	New	+$281K	0.01%	1701
2021 Q4	–	Sell	-373	Closed	-$278K	–	1874
2021 Q3	$278K	Buy	+373	New	+$279K	0.01%	1371

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Boothbay Fund Management's BIO Position: Q2 2026 in Review

Boothbay Fund Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 1,552 shares — an estimated $433K sold.

Boothbay Fund Management first reported a position in BIO in Q3 2021 and held it in 9 quarters. The position peaked at $1.66M in Q2 2025. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Boothbay Fund Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
Boothbay Fund Management sold 1,552 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $433K.
Boothbay Fund Management first reported a position in Bio-Rad Laboratories Class A in Q3 2021 and held it in 9 quarters.
Boothbay Fund Management's Bio-Rad Laboratories Class A position peaked at $1.66M in Q2 2025.
398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.